Search Results - "KAMEDA, Kunihiko"
-
1
C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: Inhibitory effect of fluvastatin
Published in Life sciences (1973) (25-01-2006)“…Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase (MMP)-9 were reported to be expressed at the macrophage-rich area in…”
Get full text
Journal Article -
2
Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina: Aomori coronary spastic angina study
Published in Journal of cardiology (01-11-2010)“…Summary Objectives We compared the efficacy of once-daily administration of nifedipine CR 40 mg (N) with that of twice-daily diltiazem R 100 mg (D) in patients…”
Get full text
Journal Article -
3
Increased Pericardial Fluid Level of Matrix Metalloproteinase-9 Activity in Patients With Acute Myocardial Infarction: Possible Role in the Development of Cardiac Rupture
Published in Circulation Journal (2006)“…Background In an animal model of acute myocardial infarction (AMI), deletion of matrix metalloproteinase (MMP)-9 results in suppression of the development of…”
Get full text
Journal Article -
4
Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction
Published in Heart and vessels (01-09-2007)“…Nicorandil, a hybrid KATP channel opener and nicotinamide nitrate, reduces no-reflow phenomenon and improves cardiac function in patients with acute myocardial…”
Get full text
Journal Article -
5
A case of suspected vasospastic angina related to S-1 administration
Published in Gan to kagaku ryoho (01-10-2007)“…A 58-year-old male with advanced gastric cancer underwent a total gastrectomy after neoadjuvant chemotherapy with paclitaxel and cisplatin. The combination…”
Get more information
Journal Article -
6
Long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor in patients with paroxysmal and persistent atrial fibrillation: importance of the timing of administration
Published in Journal of cardiology (01-02-2003)“…This study examined the long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor (ACE-I) to maintain…”
Get more information
Journal Article -
7
Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease: Possible role for left ventricular remodelling
Published in European heart journal (01-12-2003)“…Oxidative stress is implicated in the progression of heart failure, and matrix metalloproteinase (MMP) activity is increased in patients with congestive heart…”
Get full text
Journal Article -
8
Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation
Published in Journal of cardiology (01-09-2003)“…The relationship between the duration of arrhythmia and the subsequent long-term efficacy of disopyramide in preventing atrial fibrillation was investigated in…”
Get more information
Journal Article -
9
Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients
Published in Journal of cardiology (01-04-2003)“…The relationship between the efficacy of the anticholinergic action of disopyramide, cibenzoline and aprindine and age was examined in patients with paroxysmal…”
Get more information
Journal Article -
10
Relationship between long-term preventive efficacy of cibenzoline and atrial natriuretic peptide in patients with paroxysmal atrial fibrillation
Published in Journal of cardiology (01-02-2002)“…The relationship between the long-term efficacy of the antiarrhythmic agent cibenzoline in preventing lone paroxysmal atrial fibrillation (PAf) and plasma…”
Get more information
Journal Article -
11
Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatin
Published in European journal of pharmacology (10-10-2008)“…Matrix metalloproteinase (MMP), which is activated by oxidative stress, plays an important role in the development of ventricular remodeling in coronary artery…”
Get full text
Journal Article -
12
Increased Level of Pericardial Insulin-Like Growth Factor-1 in Patients With Left Ventricular Dysfunction and Advanced Heart Failure
Published in Journal of the American College of Cardiology (03-10-2006)“…Increased Level of Pericardial Insulin-Like Growth Factor-1 in Patients With Left Ventricular Dysfunction and Advanced Heart Failure Naoki Abe, Toshiro…”
Get full text
Journal Article -
13
Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction
Published in International journal of cardiology (02-11-2005)“…Matrix metalloproteinase (MMP) plays an important role in the development of ventricular remodeling in an animal model of acute myocardial infarction (AMI). We…”
Get full text
Journal Article -
14
Abstract 2657: The Increased Local Insulin-like Growth Factor-1 To IGF Binding Protein-3 Ratio In The Pathogenesis Of The Left Ventricular Hypertrophy In Humans: Augmentation By Matrix Metalloproteinase-2 Activity
Published in Circulation (New York, N.Y.) (16-10-2007)“…Abstract only Insulin-like growth factor (IGF)-1 is a potent mitogen and is said to enhance ventricular hypertrophy. IGF-1 is present as an IGF-1-IGF binding…”
Get full text
Journal Article -
15
Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease
Published in European heart journal (01-12-2003)“…Aim Oxidative stress is implicated in the progression of heart failure, and matrix metalloproteinase (MMP) activity is increased in patients with congestive…”
Get full text
Journal Article